Atrial Fibrillation Clinical Trials

28 trials recruiting in Canada.

Heart & Circulation

Recruiting Drug Device Behavioral Older adults Healthy volunteers

11 trials

Comparing REGN7508 with Apixaban for atrial fibrillation (AF)

Explore this study →

There are 2 groups in this study. Group A receives REGN7508 and Placebo. Group B, the comparison group, receives Apixaban and Placebo.

Sites in Hamilton, Longueuil and 1 more city

Phase 3
2 groups
Sites in Hamilton, Sherbrooke and 1 more city
Recruiting

Official title: Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

Atrial Fibrillation (AF) · Regeneron Pharmaceuticals

Comparing 3 approaches for atrial fibrillation (AF)

Explore this study →

There are 3 groups in this study. Group A receives REGN7508. Group B receives REGN9933. Group C, the comparison group, receives Apixaban.

Sites in Hamilton, Sherbrooke and 12 more cities

Phase 2
3 groups
Sites in Edmonton, Victoria and 12 more cities
Recruiting

Official title: Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

Atrial Fibrillation (AF) · Regeneron Pharmaceuticals

Testing PKN605 against a placebo for atrial fibrillation

Explore this study →

There are 3 groups in this study. Groups A and B receive PKN605. Group C, the placebo group, receives Placebo.

Sites in Montreal, Toronto and 8 more cities

Phase 2
3 groups
Sites in Calgary, Vancouver and 8 more cities
Recruiting

Official title: A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

Atrial Fibrillation · Novartis Pharmaceuticals

Get matched to the best-fit trials

Answer a few questions and we'll find the closest matches for atrial fibrillation.

Testing Catheter Ablation for Atrial for atrial fibrillation (AF)

Explore this study →

There are 2 groups in this study. Group A, the comparison group, receives Catheter Ablation for Atrial Fibrillation. Group B, the comparison group, receives Rate Control Medications (beta-blockers, calcium channel blockers, digoxin).

Sites in Halifax, Hamilton and 2 more cities

2 groups
Sites in Halifax, Hamilton and 2 more cities
Recruiting

Official title: Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication

Atrial Fibrillation (AF) · Nova Scotia Health Authority

Testing REGN7508 against a placebo for atrial fibrillation (AF)

Explore this study →

There are 3 groups in this study. Group A receives REGN7508. Group B receives REGN9933. Group C, the placebo group, receives Placebo.

One site, in Hamilton

Phase 3
3 groups
One site, in Hamilton
Recruiting

Official title: Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

Atrial Fibrillation (AF) · Regeneron Pharmaceuticals

Testing Etripamil against a placebo for atrial fibrillation

Explore this study →

There are 2 groups in this study. Group A, the placebo group, receives Placebo. Group B receives Etripamil.

One site, in Montreal

Phase 3
2 groups
One site, in Montreal
Recruiting

Official title: ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

Atrial Fibrillation · Milestone Pharmaceuticals Inc.

Comparing Apixaban with Rivaroxaban for atrial fibrillation

Explore this study →

There are 2 groups in this study. Group A, the comparison group, receives Apixaban. Group B, the comparison group, receives Rivaroxaban.

Sites in Ottawa, Gatineau and 5 more cities

Phase 4
2 groups
Sites in Victoria, Halifax and 5 more cities
Recruiting

Official title: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Atrial Fibrillation · Ottawa Hospital Research Institute

Comparing Medication with Pace and Ablate for atrial fibrillation

Explore this study →

There are 2 groups in this study. Group A, the comparison group, receives Medication. Group B receives Pace and Ablate.

Sites in Montreal, Halifax and 9 more cities

2 groups
Sites in Victoria, Halifax and 9 more cities
Recruiting

Official title: RAFT - Pace &Ablate

Atrial Fibrillation · Habib Khan

Testing Amiodarone Hydrochloride for atrial fibrillation new onset

Explore this study →

There are 2 groups in this study. Group A, the comparison group, receives Amiodarone Hydrochloride 200 MG. Group B receives no study treatment and is followed for comparison.

Sites in Hamilton and Toronto

Phase 3
2 groups
Sites in Hamilton and Toronto
Recruiting

Official title: Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial

Atrial Fibrillation New Onset · Population Health Research Institute

Testing Abelacimab against a placebo for atrial fibrillation (AF)

Explore this study →

There are 2 groups in this study. Group A receives Abelacimab. Group B, the placebo group, receives Placebo.

Sites in Toronto, Hamilton and 19 more cities

Phase 3
2 groups
Sites in Mira Road, Cambridge and 18 more cities
Recruiting

Official title: Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) · Anthos Therapeutics, Inc.

Comparing Antiplatelet-only strategy with Oral Anticoagulant plus background for atrial fibrillation

Explore this study →

There are 2 groups in this study. Group A, the comparison group, receives Antiplatelet-only strategy. Group B, the comparison group, receives Oral Anticoagulant plus background antiplatelet therapy.

Sites in Montreal, Toronto and 4 more cities

Phase 3
2 groups
Sites in Edmonton, London and 4 more cities
Recruiting

Official title: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Atrial Fibrillation · Icahn School of Medicine at Mount Sinai

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Get notified when a matching trial opens

We'll watch for Atrial Fibrillation trials near you.

← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.